Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

ACCC has developed a curated resource list that incorporates publications, tools, and other assets that can help cancer programs reduce disparities and improve early detection and care for vulnerable patients with prostate cancer.
Based on the barriers to integration of immunotherapies identified by the sites participating in the quality improvement project, the following webinars were developed to address specific challenges, providing training and tools to support all members of the multidisciplinary team involved in the care of patients treated with immunotherapy for cancer. Clinical Advances in Immunotherapy Ali …
ACCC has developed a curated resource library that incorporates publications, tools, and other assets that can help care team members navigate TILs and their potential in cancer therapy.
Chronic lymphocytic leukemia (CLL) is a cancer of the B-lymphocytes that may be found in the bone marrow, blood, lymph nodes, spleen and sometimes other organs. CLL is the most common leukemia in adults and accounts for one quarter of new leukemia cases annually. The average age at diagnosis is 70, and CLL is rarely seen in those under the age of 40. CLL is considered a chronic disease because it can …
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
ASCO® DIRECT Highlights 2019: Genitourinary Cancers Release Date: August 30, 2019 Expiration Date: August 30, 2020 Estimated time to complete: 30 minutes This educational activity is jointly provided by AXIS Medical Education and the Association of Community Cancer Centers (ACCC). This activity is supported in part by educational grants from Astellas and Seattle Genetics, Amgen, Celgene …
Optimizing Outcomes for Patients with Urothelial Carcinoma Release Date: September 30, 2020 Expiration Date: September 29, 2021 This educational activity is jointly provided by AXIS Medical Education and the Association of Community Cancer Centers (ACCC). This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, Genentech, Astellas and Seattle Genetics, Inc. Target audience …
A number of professional organizations, advocacy groups, and healthcare institutions provide easy-to-understand, accessible, and useful information for multiple myeloma patients and their families. This list is not comprehensive but includes a core set of resources. American Cancer Society The Society is a national voluntary organization that is focused on the elimination of cancer. Specific …
ASCO® DIRECT Highlights 2019: Hepatobiliary/Pancreatic/Gastrointestinal Cancers Release Date: August 30, 2019 Expiration Date: August 30, 2020 Estimated time to complete: 45 minutes This educational activity is jointly provided by AXIS Medical Education and the Association of Community Cancer Centers (ACCC). This activity is supported in part by educational grants from Astellas and Seattle …
Emerging Therapies for the Management of Castration-Sensitive Prostate Cancer Prostate cancer is the second most common cancer, after skin cancer, among men. It is the second leading cause of cancer death in the United States. This year, it is estimated that about 174,650 men in the United States will be diagnosed with prostate cancer and 31,620 men will die from this disease. Androgen deprivation …
ASCO DIRECT™ HIGHLIGHTS condense the most cutting-edge science and education from the world’s premier oncology event, the ASCO Annual Meeting. The abstracts chosen for presentation and discussion reflect state-of-the-art developments and recent advances in oncology that will directly impact patient care. The program features in-depth discussion and analysis on the latest scientific findings in primary …
Overcoming Obstacles in Integrating Immunotherapies for Cancer in the Community Setting Two ACCC Cancer Program members have been selected to participate in this quality improvement (QI) research study. The project is designed to assess the impact of comprehensive educational interventions on evidence-based integration of immunotherapies for cancer in the community. The educational interventions will …
The panelists participating in the conversations on "Improving Care Team Communication for Immune-Oncology Survivors" and "Meeting the Psychosocial and Physical Well-Being Needs of Immuno-Oncology Survivors," highlighted a number of resources. These and some additional materials are available below. American College of Surgeons Commission on Cancer Optimal Resources for Cancer Care (2020 …
In May 2019 CMS issued a final rule that expanded step therapy to Medicare Part B drugs but specifies that antineoplastics are to remain among the “protected classes,” and that insurers could impose prior authorization and step therapy requirements for new patients only. As cancer treatments have become increasingly targeted and complex, the potential for increased utilization of step therapy in oncology …
At the conclusion of the Case Studies in IO: A Closer Look at Care Delivery education initiative participants should be able to: Assess current vs. best practices concerning coordination and communication with the multidisciplinary cancer care team to optimize integration of cancer immunotherapies. Evaluate tools and resources for monitoring and managing immune-related adverse events associated …
Links to disease information, practice guidelines, patient education and support, patient access, lecture series, and organizations for Cutaneous Squamous Cell Carcinoma (cSCC).
Addressing Disparities and Access to Clinical Trials Among Patients with Multiple Myeloma Sikander Ailawadhi, MD Professor of Medicine, Division of Hematology/Oncology, Department of Medicine Mayo Clinic Florida Access to clinical trials is crucial to quality cancer care for every person. Learn how to identify key disparities in clinical trial access for patients with multiple …
Emerging Therapies for the Management of Castration- Sensitive Prostate Cancer Release Date: 1/29/21 Expiration Date: 1/29/22 Estimated Time to Complete: 60 minutes This educational activity is jointly provided by AXIS Medical Education and ACCC. This educational activity in supported by an educational grant from Astellas and Pfizer, Inc. Target audience The target audience for this initiative includes …
ASCO® DIRECT Highlights 2019: Gynecologic Cancers Release Date: August 30, 2019 Expiration Date: August 30, 2020 Estimated time to complete: 30 minutes This educational activity is jointly provided by AXIS Medical Education and the Association of Community Cancer Centers (ACCC). This activity is supported in part by educational grants from Astellas and Seattle Genetics, Amgen, Celgene …
Second in an IO education series, this program is offered in two formats: an on-demand webinar and as an on-site live tumor board presentation. For this project, five ACCC Cancer Program members will have an opportunity to host Case Studies in IO: A Closer Look at Care Delivery on-site at their facility. Organized around four case studies, the discussion will focus on current clinical evidence for …